Delivery Order SPE2DB24D1205-SPE2DB24FCSPF
Award Date
7/9/24
Potential Completion Date
7/30/24
Potential Value
$2K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 100 mg vials of the antiviral drug Veklury (Remdesivir). The $13,618.40 contract has an ultimate completion date of April 17, 2024. This delivery order contract is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 and a...
This is a delivery order award under a Defense Logistics Agency (DLA) Indefinite Delivery Contract (IDC) valued at $30,112.72 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of VEKLURY (remdesivir) 100 mg vials, a critical antiviral medication. The award has an ultimate completion date of April 4, 2025 and uses a firm fixed price pricing type. This order is part of a larger $999,999,999 IDC that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp is a Delivery Order (SPE2DB20D3103|SPE2DB24FP6V0) worth $13,618.40 for the supply of 100 mg VEKLURY (Remdesivir) vials. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of August 16, 2024. The contract is a Firm Fixed Price agreement with no set-aside designation, indicating open competition. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions...
This federal contract award, valued at $18,725.30, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Veklury (Remdesivir) 100 mg vials, a critical COVID-19 treatment medication. It is a firm-fixed-price delivery order contract with a completion date of December 4, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,809.20 firm fixed-price delivery order is for the supply of Veklury (Remdesivir) 100 mg vials, a medication used to treat COVID-19. The contract has an ultimate completion date of August 14, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of VEKLURY (remdesivir) 100 mg vials. The contract, valued at $15,848.80, is a firm fixed-price delivery order that runs through March 11, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and expiring in November 2026, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The award, valued at $13,618.40, is for the delivery of 100 mg vials of the antiviral drug Veklury (remdesivir). This is a firm-fixed-price delivery order contract with an ultimate completion date of August 21, 2024. The contract does not have a set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous...
This federal contract award is for the delivery of VEKLURY (Remdesivir) 100 mg vials, a pharmaceutical product used to treat COVID-19, to the Defense Logistics Agency (DLA). The award, with a ceiling value of $22,111.05, was made to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of VEKLURY (Remdesivir) 100 mg vials. The contract has a ceiling value of $8,511.50 and an ultimate completion date of September 24, 2024. The award is a firm fixed-price contract with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, has been awarded multiple federal contracts and Indefinite Delivery Contracts (IDCs) by the DLA and other...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 100 mg VEKLURY (remdesivir) vials. The contract has a ceiling value of $13,618.40 and an ultimate completion date of September 20, 2024. It is a firm-fixed-price contract and does not utilize any set-aside designations. AmerisourceBergen, through its Corporate Office Division, has been awarded numerous federal contracts and...